These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 28541484)

  • 1. Residual disease activity in psoriatic arthritis: discordance between the rheumatologist's opinion and minimal disease activity measurement.
    van Mens LJJ; Turina MC; van de Sande MGH; Nurmohamed MT; van Kuijk AWR; Baeten DLP
    Rheumatology (Oxford); 2018 Feb; 57(2):283-290. PubMed ID: 28541484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with Psoriatic Arthritis Fulfilling the Minimal Disease Activity Criteria Do Not Have Swollen and Tender Joints, but Have Active Skin.
    Marin J; Acosta Felquer ML; Ferreyra Garrot L; Ruta S; Rosa J; Soriano ER
    J Rheumatol; 2016 May; 43(5):907-10. PubMed ID: 26932341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ideal target for psoriatic arthritis? Comparison of remission and low disease activity states in a real-life cohort.
    van Mens LJJ; van de Sande MGH; van Kuijk AWR; Baeten D; Coates LC
    Ann Rheum Dis; 2018 Feb; 77(2):251-257. PubMed ID: 29080861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual symptoms and disease burden among patients with psoriatic arthritis: is a new disease activity index required?
    Kilic G; Kilic E; Nas K; Kamanlı A; Tekeoglu İ
    Rheumatol Int; 2019 Jan; 39(1):73-81. PubMed ID: 30426235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: association with disease activity and quality of life indices.
    Lubrano E; Scriffignano S; Azuaga AB; Ramirez J; Cañete JD; Perrotta FM
    RMD Open; 2020 Mar; 6(1):. PubMed ID: 32179713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application and modifications of minimal disease activity measures for patients with psoriatic arthritis treated with adalimumab: subanalyses of ADEPT.
    Mease PJ; Heckaman M; Kary S; Kupper H
    J Rheumatol; 2013 May; 40(5):647-52. PubMed ID: 23504383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasonographic evaluation in psoriatic arthritis is of major importance in evaluating disease activity.
    Michelsen B; Diamantopoulos AP; Hammer HB; Soldal DM; Kavanaugh A; Haugeberg G
    Ann Rheum Dis; 2016 Dec; 75(12):2108-2113. PubMed ID: 27091837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal disease activity and impact of disease in psoriatic arthritis: a Spanish cross-sectional multicenter study.
    Queiro R; Cañete JD; Montilla C; Abad M; Montoro M; Gómez S; Cábez A;
    Arthritis Res Ther; 2017 Mar; 19(1):72. PubMed ID: 28356155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with patient-physician discordance in a prospective cohort of patients with psoriatic arthritis: An Asian perspective.
    Wang CTM; Kwan YH; Fong W; Xiong SQ; Leung YY
    Int J Rheum Dis; 2019 Jul; 22(7):1209-1215. PubMed ID: 30942553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What are the main barriers to achieve minimal disease activity in psoriatic arthritis in real life?
    Bakirci S; Solmaz D; Al Osaimi N; Dalkilic E; Can M; Erden A; Ozisler C; Cinar M; Kilic L; Küçük A; Omma A; Yildiz F; Doğru A; Tufan A; Esmen SE; Akar S; Kalyoncu U; Aydin SZ;
    Clin Exp Rheumatol; 2019; 37(5):808-812. PubMed ID: 30767863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease activity and functional status associated with health-related quality of life and patient-acceptable symptom state in patients with psoriatic arthritis in Thailand: A cross-sectional study.
    Chiowchanwisawakit P; Srinonprasert V; Thaweeratthakul P; Katchamart W
    Int J Rheum Dis; 2019 Apr; 22(4):700-707. PubMed ID: 30666824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual Disease Activity and Associated Factors in Psoriatic Arthritis.
    Lubrano E; Scriffignano S; Perrotta FM
    J Rheumatol; 2020 Oct; 47(10):1490-1495. PubMed ID: 31676704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual disease activity and treatment adjustments in psoriatic arthritis in current clinical practice.
    van Mens LJJ; van de Sande MGH; Fluri IA; Atiqi S; van Kuijk AWR; Baeten DLP
    Arthritis Res Ther; 2017 Oct; 19(1):226. PubMed ID: 29017591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Need for Improvement in Current Treatment of Psoriatic Arthritis: Study of an Outpatient Clinic Population.
    Michelsen B; Diamantopoulos AP; Høiberg HK; Soldal DM; Kavanaugh A; Haugeberg G
    J Rheumatol; 2017 Apr; 44(4):431-436. PubMed ID: 28148701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA).
    Theander E; Husmark T; Alenius GM; Larsson PT; Teleman A; Geijer M; Lindqvist UR
    Ann Rheum Dis; 2014 Feb; 73(2):407-13. PubMed ID: 23355078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal Disease Activity and Patient-Acceptable Symptom State in Psoriatic Arthritis: A Real-World Evidence Study With Ustekinumab.
    Queiro R; Brandy A; Rosado MC; Lorenzo A; Coto P; Carriles C; Alperi M; Ballina J
    J Clin Rheumatol; 2018 Oct; 24(7):381-384. PubMed ID: 29509560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of minimal disease activity in Australian patients with Psoriatic Arthritis: Assessing the outcome of national funding criteria for biologic disease-modifying antirheumatic drug prescribing.
    Pontifex EK; Dissanayake K; Bursill D; Gill T
    Int J Rheum Dis; 2019 Feb; 22(2):262-268. PubMed ID: 30450819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of training on concordance among rheumatologists and dermatologists in the assessment of patients with psoriasis and psoriatic arthritis.
    Salvarani C; Girolomoni G; Di Lernia V; Gisondi P; Tripepi G; Egan CG; Marchesoni A;
    Semin Arthritis Rheum; 2016 Dec; 46(3):305-311. PubMed ID: 27470190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of Patient-Physician Discordance in Global Assessment in Psoriatic Arthritis: A Multicenter European Study.
    Desthieux C; Granger B; Balanescu AR; Balint P; Braun J; Canete JD; Heiberg T; Helliwell PS; Kalyoncu U; Kvien TK; Kiltz U; Niedermayer D; Otsa K; Scrivo R; Smolen J; Stamm TA; Veale DJ; de Vlam K; de Wit M; Gossec L
    Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1606-1611. PubMed ID: 27998026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of one-year treat-to-target strategy in early psoriatic arthritis: data of an open-label REMARCA study.
    Korotaeva TV; Loginova EY; Getiya TS; Nasonov EL
    Ter Arkh; 2018 May; 90(5):22-29. PubMed ID: 30701886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.